company background image
MVP logo

Medical Developments International CHIA:MVP Stock Report

Last Price

AU$0.42

Market Cap

AU$47.3m

7D

3.7%

1Y

-59.3%

Updated

02 Jan, 2025

Data

Company Financials +

Medical Developments International Limited

CHIA:MVP Stock Report

Market Cap: AU$47.3m

MVP Stock Overview

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. More details

MVP fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 82.8% below our estimate of its fair value

Earnings are forecast to grow 93.09% per year

Trading at good value compared to peers and industry

Risk Analysis

Does not have a meaningful market cap (A$47M)

Shareholders have been diluted in the past year


My Notes

Capture your thoughts, links and company narrative

Medical Developments International Limited Competitors

Little Green Pharma

ASX:LGP

AU$37.9m

Starpharma Holdings

ASX:SPL

AU$46.0m

Vitura Health

ASX:VIT

AU$47.7m

Nyrada

ASX:NYR

AU$19.7m

Price History & Performance

Summary of share price highs, lows and changes for Medical Developments International
Historical stock prices
Current Share PriceAU$0.42
52 Week HighAU$1.05
52 Week LowAU$0.38
Beta1.48
1 Month Change3.66%
3 Month Change-6.59%
1 Year Change-59.33%
3 Year Change-91.40%
5 Year Change-95.20%
Change since IPO-65.16%

Recent News & Updates

Recent updates

Shareholder Returns

MVPAU PharmaceuticalsAU Market
7D3.7%4.4%-0.6%
1Y-59.3%-9.5%7.4%

Return vs Industry: MVP underperformed the Australian Pharmaceuticals industry which returned -9.5% over the past year.

Return vs Market: MVP underperformed the Australian Market which returned 7.4% over the past year.

Price Volatility

Is MVP's price volatile compared to industry and market?
MVP volatility
MVP Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement10.3%
Market Average Movement8.0%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market3.0%

Stable Share Price: MVP has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: MVP's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1972n/aBrent MacGregormedicaldev.com

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures.

Medical Developments International Limited Fundamentals Summary

How do Medical Developments International's earnings and revenue compare to its market cap?
MVP fundamental statistics
Market capAU$47.32m
Earnings (TTM)-AU$40.99m
Revenue (TTM)AU$33.15m

1.4x

P/S Ratio

-1.2x

P/E Ratio

Is MVP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MVP income statement (TTM)
RevenueAU$33.15m
Cost of RevenueAU$8.78m
Gross ProfitAU$24.37m
Other ExpensesAU$65.36m
Earnings-AU$40.99m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.36
Gross Margin73.50%
Net Profit Margin-123.66%
Debt/Equity Ratio0%

How did MVP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 00:41
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medical Developments International Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dennis HulmeAPP Securities Pty Ltd.
Anubhav SaxenaBell Potter
Martyn JacobsCanaccord Genuity